Literature DB >> 21457097

Fgf-18 is required for osteogenesis but not angiogenesis during long bone repair.

Björn Behr1, Michael Sorkin, Alina Manu, Marcus Lehnhardt, Michael T Longaker, Natalina Quarto.   

Abstract

Bone regeneration is a complex event that requires the interaction of numerous growth factors. Fibroblast growth factor (Fgf)-ligands have been previously described for their importance in osteogenesis during development. In the current study, we investigated the role of Fgf-18 during bone regeneration. By utilizing a unicortical tibial defect model, we revealed that mice haploinsufficient for Fgf-18 have a markedly reduced healing capacity as compared with wild-type mice. Reduced levels of Runx2 and Osteocalcin but not Vegfa accompanied the impaired bone regeneration. Interestingly, our data indicated that upon injury angiogenesis was not impaired in Fgf-18(+/-) mice. Moreover, other Fgf-ligands and Bmp-2 could not compensate for the loss of Fgf-18. Finally, application of FGF-18 protein was able to rescue the impaired healing in Fgf-18(+/-) mice. Thus, we identified Fgf-18 as an important mediator of bone regeneration, which is required during later stages of bone regeneration. This study provides hints on how to engineering efficiently programmed bony tissue for long bone repair.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457097      PMCID: PMC3142654          DOI: 10.1089/ten.TEA.2010.0719

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  29 in total

1.  Effects of basic fibroblast growth factor on bone formation in vitro.

Authors:  E Canalis; M Centrella; T McCarthy
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18.

Authors:  N Ohbayashi; M Hoshikawa; S Kimura; M Yamasaki; S Fukui; N Itoh
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

Review 3.  Craniosynostosis: genes and mechanisms.

Authors:  A O Wilkie
Journal:  Hum Mol Genet       Date:  1997       Impact factor: 6.150

4.  Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.

Authors:  David Davidson; Antoine Blanc; Dominic Filion; Huifen Wang; Paul Plut; Gerald Pfeffer; Michael D Buschmann; Janet E Henderson
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

5.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.

Authors:  E W Jabs; X Li; A F Scott; G Meyers; W Chen; M Eccles; J I Mao; L R Charnas; C E Jackson; M Jaye
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

6.  Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.

Authors:  G A Bellus; K Gaudenz; E H Zackai; L A Clarke; J Szabo; C A Francomano; M Muenke
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

7.  FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation.

Authors:  M C Hu; W R Qiu; Y P Wang; D Hill; B D Ring; S Scully; B Bolon; M DeRose; R Luethy; W S Simonet; T Arakawa; D M Danilenko
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

8.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.

Authors:  R Shiang; L M Thompson; Y Z Zhu; D M Church; T J Fielder; M Bocian; S T Winokur; J J Wasmuth
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

9.  A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.

Authors:  G A Bellus; I McIntosh; E A Smith; A S Aylsworth; I Kaitila; W A Horton; G A Greenhaw; J T Hecht; C A Francomano
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

10.  Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats.

Authors:  H Nagai; R Tsukuda; H Mayahara
Journal:  Bone       Date:  1995-03       Impact factor: 4.398

View more
  13 in total

1.  Local Application of Isogenic Adipose-Derived Stem Cells Restores Bone Healing Capacity in a Type 2 Diabetes Model.

Authors:  Christoph Wallner; Stephanie Abraham; Johannes Maximilian Wagner; Kamran Harati; Britta Ismer; Lukas Kessler; Hannah Zöllner; Marcus Lehnhardt; Björn Behr
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

Review 2.  Biology of Bone: The Vasculature of the Skeletal System.

Authors:  Emma C Watson; Ralf H Adams
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

3.  A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model.

Authors:  Björn Behr; Michael Sorkin; Marcus Lehnhardt; Andrea Renda; Michael T Longaker; Natalina Quarto
Journal:  Tissue Eng Part A       Date:  2012-02-28       Impact factor: 3.845

4.  Investigating the role of FGF18 in the cultivation and osteogenic differentiation of mesenchymal stem cells.

Authors:  Eunyi Jeon; Ye-Rang Yun; Wonmo Kang; Sujin Lee; Young-Hag Koh; Young-Hyag Koh; Hae-Won Kim; Chang Kook Suh; Jun-Hyeog Jang
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

5.  Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration.

Authors:  Christoph Wallner; Jessica Schira; Johannes Maximilian Wagner; Matthias Schulte; Sebastian Fischer; Tobias Hirsch; Wiltrud Richter; Stephanie Abraham; Ulrich Kneser; Marcus Lehnhardt; Björn Behr
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 6.  Fibroblast growth factor signaling in skeletal development and disease.

Authors:  David M Ornitz; Pierre J Marie
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

7.  Osteochondral tissue engineering using a biphasic collagen/GAG scaffold containing rhFGF18 or BMP-7 in an ovine model.

Authors:  Alan Getgood; Frances Henson; Carrie Skelton; Roger Brooks; Hans Guehring; Lisa A Fortier; Neil Rushton
Journal:  J Exp Orthop       Date:  2014-09-26

Review 8.  Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models.

Authors:  Nan Su; Min Jin; Lin Chen
Journal:  Bone Res       Date:  2014-04-29       Impact factor: 13.567

Review 9.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

10.  Human scaphoid non-unions exhibit increased osteoclast activity compared to adjacent cancellous bone.

Authors:  Jessica Schira; Matthias Schulte; Carmen Döbele; Christoph Wallner; Stephanie Abraham; Adrien Daigeler; Ulrich Kneser; Marcus Lehnhardt; Björn Behr
Journal:  J Cell Mol Med       Date:  2015-09-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.